BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DiStefano JK. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cell Mol Life Sci 2020;77:2079-90. [PMID: 31760464 DOI: 10.1007/s00018-019-03390-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ajah AA, Lembede BW, Nkomozepi P, Erlwanger KH, Nyakudya TT. Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life 2022;12:790. [DOI: 10.3390/life12060790] [Reference Citation Analysis]
2 Pinheiro FC, Sperb-ludwig F, Schwartz IVD. KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword. Cell Mol Life Sci 2020;77:3465-6. [DOI: 10.1007/s00018-020-03575-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Arechederra M, Recalde M, Gárate-Rascón M, Fernández-Barrena MG, Ávila MA, Berasain C. Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease. Cancers (Basel) 2021;13:1265. [PMID: 33809263 DOI: 10.3390/cancers13061265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 DiStefano JK, Gerhard GS. NAFLD in normal weight individuals. Diabetol Metab Syndr 2022;14:45. [PMID: 35331317 DOI: 10.1186/s13098-022-00814-z] [Reference Citation Analysis]
5 de Paula Dias Moreira L, Enes BN, de São José VPB, Toledo RCL, Ladeira LCM, Cardoso RR, da Silva Duarte V, Hermsdorff HHM, de Barros FAR, Martino HSD. Chia (Salvia hispanica L.) Flour and Oil Ameliorate Metabolic Disorders in the Liver of Rats Fed a High-Fat and High Fructose Diet. Foods 2022;11:285. [DOI: 10.3390/foods11030285] [Reference Citation Analysis]
6 Muhammad N, Lembede BW, Erlwanger KH. Zingerone Administered Neonatally Prevents the Subsequent Development of High Dietary Fructose-Induced Fatty Liver in Sprague Dawley Rats. J Med Food 2021. [PMID: 33512269 DOI: 10.1089/jmf.2020.0189] [Reference Citation Analysis]
7 Koo S, Kim M, Cho HM, Kim I. Maternal high-fructose intake during pregnancy and lactation induces metabolic syndrome in adult offspring. Nutr Res Pract 2021;15:160-72. [PMID: 33841721 DOI: 10.4162/nrp.2021.15.2.160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ramos-Lopez O, Milagro FI, Riezu-Boj JI, Martinez JA. Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition. Inflamm Res 2021;70:29-49. [PMID: 33231704 DOI: 10.1007/s00011-020-01425-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Roeb E, Weiskirchen R. Fructose and Non-Alcoholic Steatohepatitis. Front Pharmacol 2021;12:634344. [PMID: 33628193 DOI: 10.3389/fphar.2021.634344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
10 Veronesi VB, Pioli MR, de Souza DN, Teixeira CJ, Murata GM, Santos-Silva JC, Hecht FB, Vicente JM, Bordin S, Anhê GF. Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats. Biomed Pharmacother 2021;141:111807. [PMID: 34120066 DOI: 10.1016/j.biopha.2021.111807] [Reference Citation Analysis]
11 Novelle MG, Bravo SB, Deshons M, Iglesias C, García-Vence M, Annells R, da Silva Lima N, Nogueiras R, Fernández-Rojo MA, Diéguez C, Romero-Picó A. Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation. iScience 2021;24:102071. [PMID: 33554072 DOI: 10.1016/j.isci.2021.102071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chávez-rodríguez L, Escobedo-calvario A, Salas-silva S, Miranda-labra RU, Bucio L, Souza V, Gutiérrez-ruiz MC, Gomez-quiroz LE. Fructose Consumption and Hepatocellular Carcinoma Promotion. Livers 2021;1:250-62. [DOI: 10.3390/livers1040020] [Reference Citation Analysis]
13 Chi Y, Youn DY, Xiaoli AM, Liu L, Qiu Y, Kurland IJ, Pessin JB, Yang F, Pessin JE. Comparative impact of dietary carbohydrates on the liver transcriptome in two strains of mice. Physiol Genomics 2021;53:456-72. [PMID: 34643091 DOI: 10.1152/physiolgenomics.00053.2021] [Reference Citation Analysis]
14 Busnatu SS, Salmen T, Pana MA, Rizzo M, Stallone T, Papanas N, Popovic D, Tanasescu D, Serban D, Stoian AP. The Role of Fructose as a Cardiovascular Risk Factor: An Update. Metabolites 2022;12:67. [PMID: 35050189 DOI: 10.3390/metabo12010067] [Reference Citation Analysis]
15 Dabravolski SA, Bezsonov EE, Baig MS, Popkova TV, Orekhov AN. Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases. Int J Mol Sci 2021;22:6949. [PMID: 34203309 DOI: 10.3390/ijms22136949] [Reference Citation Analysis]
16 Prasatthong P, Meephat S, Rattanakanokchai S, Bunbupha S, Prachaney P, Maneesai P, Pakdeechote P. Hesperidin ameliorates signs of the metabolic syndrome and cardiac dysfunction via IRS/Akt/GLUT4 signaling pathway in a rat model of diet-induced metabolic syndrome. Eur J Nutr 2021;60:833-48. [PMID: 32462317 DOI: 10.1007/s00394-020-02291-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 DiStefano JK. NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment. Endocrinology 2020;161:bqaa134. [PMID: 32776116 DOI: 10.1210/endocr/bqaa134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
18 Khodorova NV, Rietman A, Rutledge DN, Schwarz J, Piedcoq J, Pilard S, Siebelink E, Kok FJ, Tomé D, Mensink M, Azzout-Marniche D. Urinary Medium-Chained Acyl-Carnitines Sign High Caloric Intake whereas Short-Chained Acyl-Carnitines Sign High -Protein Diet within a High-Fat, Hypercaloric Diet in a Randomized Crossover Design Dietary Trial. Nutrients 2021;13:1191. [PMID: 33916877 DOI: 10.3390/nu13041191] [Reference Citation Analysis]
19 Piras IS, Gerhard GS, DiStefano JK. Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media. Cell Physiol Biochem 2020;54:1068-82. [PMID: 33095528 DOI: 10.33594/000000288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Santos JPMD, Maio MC, Lemes MA, Laurindo LF, Haber JFDS, Bechara MD, Prado PSD Jr, Rauen EC, Costa F, Pereira BCA, Flato UAP, Goulart RA, Chagas EFB, Barbalho SM. Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future. Int J Mol Sci 2022;23:498. [PMID: 35008925 DOI: 10.3390/ijms23010498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Xia SJ, Tang LZ, Li WH, Xu ZS, Zhang LL, Cheng FG, Chen HX, Wang ZH, Luo YC, Dai AN, Fan JG. Serum syndecan-4 is associated with nonalcoholic fatty liver disease. J Dig Dis 2021. [PMID: 34374198 DOI: 10.1111/1751-2980.13037] [Reference Citation Analysis]
22 Simons N, Veeraiah P, Simons PIHG, Schaper NC, Kooi ME, Schrauwen-Hinderling VB, Feskens EJM, van der Ploeg EMCL, Van den Eynde MDG, Schalkwijk CG, Stehouwer CDA, Brouwers MCGJ. Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial. Am J Clin Nutr 2021;113:391-400. [PMID: 33381794 DOI: 10.1093/ajcn/nqaa332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]